Gene: CLPTM1
Official Full Name: CLPTM1 regulator of GABA type A receptor forward traffickingprovided by HGNC
Gene Summary: Predicted to enable GABA receptor binding activity. Predicted to be involved in regulation of T cell differentiation in thymus. Located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38507 | CLPTM1 Knockout cell line (HeLa) | Human | CLPTM1 | 1:3~1:6 | Negative | Online Inquiry |
KO38508 | CLPTM1 Knockout cell line (HCT 116) | Human | CLPTM1 | 1:2~1:4 | Negative | Online Inquiry |
KO38509 | CLPTM1 Knockout cell line (HEK293) | Human | CLPTM1 | 1:3~1:6 | Negative | Online Inquiry |
KO38510 | CLPTM1 Knockout cell line (A549) | Human | CLPTM1 | 1:3~1:4 | Negative | Online Inquiry |
CLPTM1 Gene Knockout Cell Lines are meticulously engineered cellular models that feature the complete deletion of the CLPTM1 gene. This specific genetic alteration allows researchers to explore the roles and pathways associated with this gene in various biological contexts. The CLPTM1 gene has been implicated in cellular processes such as apoptosis, cell proliferation, and stress response mechanisms, making these knockout cell lines invaluable for elucidating its functional contributions.
The primary function of CLPTM1 Gene Knockout Cell Lines lies in their ability to facilitate the study of gene function and regulation. By removing the CLPTM1 gene, researchers can assess changes in cellular behavior, protein expression, and signaling pathways compared to wild-type cells. This advantageous setup is instrumental in investigating potential therapeutic targets and understanding disease mechanisms, particularly in cancer research where the gene's expression may correlate with tumor progression.
In scientific and clinical research, these cell lines are essential for developing novel treatment strategies and therapeutic interventions. They provide a reliable platform for high-throughput screening of compounds, gene function analysis, and the investigation of gene-environment interactions. Additionally, their consistent performance across various assays renders them a cornerstone in both preclinical and translational research efforts.
One unique selling point of CLPTM1 Gene Knockout Cell Lines is their robustness and reproducibility, which are critical for obtaining reliable data. Unlike alternative models that may exhibit variable expression levels or incomplete gene editing, these knockout lines offer a definitive system for investigating specific genetic contributions in a controlled manner. This eliminates confounding variables, thereby enhancing the reliability of experimental outcomes.
For researchers and clinicians, investing in CLPTM1 Gene Knockout Cell Lines translates to reduced experimentation time and improved accuracy in results, ultimately propelling research toward meaningful discoveries. By choosing these specialized cell lines, users are equipped with the tools necessary to unlock innovative solutions within the biotech and pharmaceutical realms.
Our company prides itself on its extensive expertise in developing high-quality biological products that support the evolving needs of the scientific community. Our commitment to excellence and innovation ensures that our offerings, including the CLPTM1 Gene Knockout Cell Lines, are tailored to empower researchers in their pursuit of scientific knowledge and breakthrough therapies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.